Inmune Bio, Inc.
INMB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001711754
No open-market purchases or sales by Inmune Bio, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $7.08M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Inmune Bio, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 57 | 2 | 67 | +12 |
| Shares | 4.57M | 1.41M | 5.35M | +2.20M (+69.5%) |
| Value | $40.3M | $12.4M | $28.8M | +$984.1K (+3.5%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Inmune Bio, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 939,468 | $5.06M | 0.00% |
| Renaissance Technologies LLC | 107,200 | $577.8K | 0.00% |
| Heights Capital Management, Inc | 60,978 | $328.7K | 0.24% |
| XTX Topco Ltd | 46,253 | $249.3K | 0.02% |
| Squarepoint Ops LLC | 33,701 | $181.6K | 0.00% |
| Diametric Capital, LP | 29,455 | $158.8K | 0.08% |
| Sanctuary Advisors, LLC | 21,045 | $102.5K | 0.00% |
| HSBC Holdings PLC | 18,790 | $100.0K | 0.00% |
| Jane Street Group, LLC | 14,725 | $79.4K | 0.00% |
| Dimensional Fund Advisors LP | 14,648 | $79.0K | 0.00% |
| Occudo Quantitative Strategies LP | 13,482 | $72.7K | 0.01% |
| Two Sigma Investments, LP | 12,184 | $65.7K | 0.00% |
| Prelude Capital Management, LLC | 10,727 | $57.8K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 6,809 | $36.7K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,082 | $16.6K | 0.00% |
| Cranbrook Wealth Management, LLC | 1,350 | $7.28K | 0.00% |
| Nisa Investment Advisors, LLC | 118 | $636 | 0.00% |
| Sterling Capital Management LLC | 13 | $70 | 0.00% |
| CWM, LLC | 22 | $0 | 0.00% |
Sold out (7)
Institutions that held Inmune Bio, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Susquehanna International Group, LLP | 42,772 | $377.2K |
| Man Group plc | 24,388 | $215.1K |
| Janney Montgomery Scott LLC | 21,688 | $191.0K |
| Alpine Global Management, LLC | 11,559 | $102.0K |
| Simplex Trading, LLC | 5,786 | $51.0K |
| Qube Research & Technologies Ltd | 3,384 | $29.8K |
| Redwood Wealth Management Group, LLC | 2,200 | $19.4K |
Not filed for Q3 2024 yet (2)
Institutions that held Inmune Bio, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 812,895 | $7.17M |
| CVI Holdings, LLC | 596,372 | $5.26M |